An interventional study of Placebo and ConcenTrace in Dehydration (Physiology), sponsored by Arizona State University. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-05.
Sponsored by Arizona State University · Not applicable, Interventional, and Basic science
It is well established that post-exercise rehydration with electrolyte solutions is more effective than plain water. However, most commercially available drinks are high in electrolytes but lack some essential trace minerals. This study aims to examine the impact of a higher-electrolyte sports drink compared with a low-electrolyte, trace-mineral-rich solution and water on the time course and extent of rehydration after exercise-induced dehydration.
Protocol Before the start of the study eligible participants will visit our lab to conduct a screening of medical history, weight, height, and a onetime assessment of body composition via BIA and Training history. This visit will take place at least one day before the actual start of the study and typically lasts no longer than 30 minutes. During this visit participants will be given two questionnaires, one regarding the physical activity readiness of the participant, and another one regarding their health history. If a participant does not meet the physical criteria and does not pass both questionnaires, they will be given a $25 digital Tango gift card for their brief visit to our lab. Participants who do pass will be given a scheduled date and time to visit the lab again for their first official trial.
At the start of the study subjects will visit the lab after at least 10h of fast and they will consume a light breakfast. An intravenous catheter will be place in an antecubital vein and a blood sample will be taken after 20 min for baseline. A baseline skin hydration reading will also be taken at this time. Subjects will void their bladders and a body weight will be taken.
Dehydration:
Consistent with the study by Shirreffs et al (2007) and based on our previous work, dehydration will be accomplished on the morning of testing via mild exercise and heat exposure to elicit a body weight loss of -2%. The subjects will perform four bouts of 25-minutes low-intensity exercise and 5 min rest (alternating cycling \& walking) or till they reach -2% of body weight dehydration.
Rehydration:
Upon losing 2% body weight, participants will be instructe to rinse off their face to get rid of excess sweat. This is followed by a 20 minutes rest period in a thermo-comfortable environment, a dehydrated baseline blood sample will be taken, along with a dehydrated skin hydration reading and subject will start the rehydration protocol.
The volunteers will consume one of the three drinks below in a cross over balance mode. During the first hour four equal doses will be consumed in15-minutes intervals at a total volume of 150% of their body weight loss.
Trials/Drinks (block randomization will be used to assign individual participants to each specific trial/drink using their ID number):
See the study design expressed as a figure below:
Measurements:
All measurements will be performed at one of the test rooms at our lab facility that boarders the room where participants can relax and wait out the end of the study day. When certain measurements need to be performed they simply move from one room to the next. Duration of taking blood and urine samples will take not more than 30-90 seconds each and perceptual data will take 30-60 seconds to be reported. To allow to perform all measurements, participants will remain supervised by a team member in the lab for up to 7 hours per trial. Therefore, there will be a separate space available that allows for self-study or watching TV that includes a chair and table to work on and a couch to relax.
Blood samples (7 per trial):
Blood samples will be taken via a venous catheter attached to an extension tube and a stopcock. After each blood sample sterile saline solution will be infused in the extention tube to avoid clotting. The iv catheter will be placed by one of the Clinical Research Center phlebotomists. A total of seven 10 milliliters blood samples will be collected on the euhydrated baseline, dehydrated baseline and at 30, 60, 120, 180, and 240 minutes of the rehydration period.
All samples will be analyzed for glucose, osmolality, total plasma protein, hematocrit, hemoglobin (for plasma volume changes), sodium, potassium, and chloride.
Urine samples (6 per trial):
Urine samples will be provided from the subjects in a urine cup. The cup will be placed in the pass-through window where a lab technician will receive it and process it.
Urine samples will be collected using \~900 milliliters cups at euhydrated baseline, dehydrated baseline and cumulative totals will be collected at 60, 120, 180, and 240 minutes of the rehydration period. All samples will be analyzed for urine osmolality, specific gravity, volume, sodium, and potassium.
Sweat samples (1 per trial):
Sweat samples will be collected with sweat patches. The sweat patches are like a band-aid that it will be placed on the forearm and stay there for approximately 30 min to absorb sweat. After 30 minutes the patch will be removed and the sweat sample will be extracted by centrifugation in the lab.
Sweat samples will be collected during the first 30 min of exercise to assess sodium and potassium content.
Skin Hydration (6 per trial):
Skin hydration will be measured with a pen-like instrument that applies a very light pressure on the skin. This does not cause any pain or skin irritation.
Skin hydration will be measured on the face (inner zygomatic bone), arm (bicep brachii) at euhydrated baseline, 30 minutes after the end of dehydration, and at 60, 120, 180, and 240 minutes of rehydration.
Gastrointestinal Symptoms (6 per trial):
Gastrointestinal symptoms will be assessed at 1, 2, 3 and 4 hours of rehydration via Gastrointestinal Symptom Rating Scale (GSRS).
Perceptual Data (6 per trial, maximal 9 minutes):
Thirst, stomach fullness, and taste, assessed via a visual analog scale.
201 studies on the registry are indexed under Dehydration; 28 are open to participants now.
This study's enrollment of 15 is below the median of 43 across 145 interventional studies indexed under Dehydration.
Browse Dehydration studies →Arizona State University is the lead sponsor of 238 studies on the registry; 42 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Beverage with ConcenTrace minerals
Dietary Supplement: ConcenTrace
Beverage with high level of trace elements but no sugar
Dietary Supplement: ZeroLyte
Water with non caloric, non-sodium containing sweetner
Dietary Supplement: Placebo
Non- calorically sweetened Water
1.25 milliliter of concentrace per liter
Beverage with 1 pack of ZeroLyte per 500 milliliter of water
Net Fluid Balance
Body water Retention after exercise-induced dehydration
Time frame: at 60 minutes, 120 minutes, 180 minutes and 240 minutes of rehydration
Urine volume
Urine volume during the rehydration period
Time frame: 1, 2, 3, and 4 hour of the rehydration period
Free water clearance
Free water clearance during the rehydration period
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Osmotic Clearance
Osmotic renal clearance during the rehydration period
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Skin Hydration
Skin hydration at the face assessed with a moisture meter.
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Plasma Volume
Changes in Plasma Volume during rehydration based on hematocrit and hemoglobin
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Stomach fullness
Stomach fullness assessed during dehydration
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Gastrointestinal symptoms
Gastrointestinal symptoms assessed with the structured assessment of gastrointestinal symptoms scale
Time frame: At the end of the 4 hours rehydration period
Plasma Osmolality
Plasma osmolality during rehydration
Time frame: 1, 2, 3, and 4 hours of the rehydration period
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Mar 2025 to primary completion in Aug 2025, 5 months.
Of 65 non-industry interventional studies with no phase under Dehydration, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 18. This study's 5 months is below that.
Counting every sponsor, half of 73 studies reached it within 9 months; a quarter within 5 and three quarters within 18.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.